• LAST PRICE
    0.5670
  • TODAY'S CHANGE (%)
    Trending Down-0.0980 (-14.7368%)
  • Bid / Lots
    0.5692/ 2
  • Ask / Lots
    0.5699/ 14
  • Open / Previous Close
    0.6650 / 0.6650
  • Day Range
    Low 0.5116
    High 0.6800
  • 52 Week Range
    Low 0.2449
    High 4.0377
  • Volume
    869,567
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.6666
TimeVolumeRNLX
09:32 ET153350.67
09:34 ET35000.68
09:36 ET89980.6521
09:39 ET1000.67
09:43 ET19000.66
09:45 ET79200.6521
09:48 ET25350.6511
09:52 ET35330.651
09:56 ET62580.64
09:57 ET41620.635
09:59 ET21000.630501
10:01 ET25010.6295
10:06 ET189510.6286
10:08 ET248800.6114
10:10 ET182020.6
10:12 ET61000.6
10:14 ET49000.609799
10:15 ET226940.5999
10:17 ET17290.5999
10:19 ET153000.6095
10:21 ET103000.6199
10:24 ET21000.6198
10:26 ET65000.6189
10:30 ET10000.6189
10:37 ET89760.612
10:44 ET310020.5563
10:46 ET12000.5842
10:48 ET22890.57231
10:50 ET38000.5925
10:51 ET9190.6049
10:53 ET3740.595
10:55 ET8400.6
10:57 ET59700.5563
11:00 ET152000.59
11:02 ET110000.5563
11:06 ET399910.6
11:08 ET1000.6
11:09 ET4920.5991
11:11 ET43450.6
11:13 ET1000.5997
11:15 ET63080.599
11:27 ET10000.592
11:31 ET3250.59
11:33 ET2150.5916
11:42 ET1700.5916
11:44 ET3590.5643
11:45 ET1000.5739
11:51 ET52710.57
11:54 ET293740.54
11:56 ET10000.5595
11:58 ET87270.5597
12:00 ET1000.5793
12:02 ET49960.55
12:03 ET10000.55
12:07 ET7510.559351
12:09 ET1300.5762
12:12 ET17000.5599
12:14 ET102000.5599
12:16 ET1000.56
12:23 ET34800.5499
12:30 ET127370.5499
12:34 ET10000.549699
12:38 ET57960.54
12:39 ET50760.548898
12:45 ET30000.5492
12:48 ET5000.5492
12:52 ET78000.5446
12:54 ET95220.5498
12:56 ET40000.5472
12:57 ET34430.5402
12:59 ET20000.5424
01:01 ET143980.541199
01:03 ET10000.5432
01:08 ET9500.5432
01:10 ET6840.542778
01:12 ET12000.5416
01:17 ET53790.5381
01:19 ET108810.5379
01:26 ET3000.5378
01:28 ET62770.536
01:35 ET50000.535
01:37 ET25000.52745
01:39 ET4000.5276
01:48 ET132940.5366
01:50 ET5870.5325
01:51 ET11000.5328
01:53 ET213130.5433
01:55 ET5000.5328
01:57 ET64410.538
02:00 ET3000.5377
02:02 ET7000.5377
02:04 ET825420.5472
02:06 ET8000.5572
02:08 ET10000.5594
02:09 ET15470.5561
02:11 ET32580.5558
02:13 ET481860.5601
02:15 ET59240.56
02:18 ET20000.5601
02:24 ET89000.56
02:27 ET10000.56
02:29 ET65000.5601
02:31 ET7000.5601
02:33 ET44010.56
02:40 ET22000.56
02:49 ET51000.56
02:56 ET5000.5601
03:02 ET157170.5601
03:09 ET1660.5601
03:12 ET9660.56005
03:16 ET102830.5601
03:20 ET20340.5601
03:21 ET5330.56
03:23 ET72100.5629
03:25 ET30000.5633
03:27 ET2510.5623
03:32 ET121000.5633
03:34 ET20330.563075
03:36 ET18000.5633
03:38 ET98000.563858
03:41 ET80000.5665
03:45 ET23000.5664
03:50 ET7530.5665
03:54 ET4200.5665
03:56 ET38000.5665
03:57 ET38270.56885
03:59 ET103820.567
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRNLX
Renalytix PLC
47.6M
-0.6x
---
United StatesICCM
Icecure Medical Ltd
51.2M
-3.7x
---
United StatesNMTC
Neuroone Medical Technologies Corp
29.6M
-1.5x
---
United StatesRBOT
Vicarious Surgical Inc
48.5M
-0.8x
---
United StatesAKLI
Akili Inc
35.0M
-0.6x
---
United StatesAMIX
Autonomix Medical Inc
50.7M
-5.3x
---
As of 2024-05-15

Company Information

Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX platform, is designed to scale across kidney disease conditions beyond diabetic kidney disease. It is evaluating a range of indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and COVID-related kidney disease. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Contact Information

Headquarters
Finsgate, 5-7 Cranwood StreetLONDON, United Kingdom EC1V 9EE
Phone
292-071-0570
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$47.6M
Revenue (TTM)
$2.4M
Shares Outstanding
77.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
3.02
EPS
$-0.91
Book Value
$0.15
P/E Ratio
-0.6x
Price/Sales (TTM)
19.8
Price/Cash Flow (TTM)
---
Operating Margin
-1,592.57%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.